About the Journal
Aims and scope
Pain and Therapy is a PubMed-indexed, international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.
The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.
Moving forward from traditional publishing, Pain and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include slide decks, videos, animations, audioslides, and/or video abstracts. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.
Pain and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the International Committee of Medical Journal Editors (ICMJE) and Good Publication Practice (GPP3) policies on acknowledgments/disclosures. Proposals for supplements are welcomed and should be addressed to firstname.lastname@example.org.
Pain and Therapy's rapid publication, personalized service, and open access is funded by article processing charges. Current fees are: £250/ €340/ $380 per typeset page. Please note, all manuscripts are thoroughly peer reviewed and accepted/rejected based purely on the merit of the content.
For more information about the journal or to submit a presubmission enquiry, please contact email@example.com.
Indexing: EMBASE, Google Scholar, PubMed, PubMed Central, OCLC, Summon by Serial Solutions
Published: Online. Articles are published online as soon as the author approves their proofs as “online first.” Once your article is online, it has full pagination and a DOI number, making it instantly citable. Paginated issues are collated twice a year (June and December).
Rejection Rate: 35%
eISSN: 2193-651X↑ Back to top